Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy

• Status: Active, not recruiting
• Trial end date: 2021-12-30
• Target enrollment: 0
• Participant gender: Female

Summary

This randomized controlled trial includes pregnant women with anemia. They are randomized to IV iron infusions or to oral iron supplementation. Pregnancy outcomes are assessed.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Arizona
• Collaborator: AMAG Pharmaceuticals, Inc.
• Treatments: Ferrosoferric Oxide

Criteria

Inclusion Criteria:

• Maternal age >/= 18

• Singleton gestation

• >/=20 weeks gestation, <37 weeks gestation

• Hemoglobin <11g/dL and/or hematocrit <33%

• Able to read/speak English or Spanish

Exclusion Criteria:

• Maternal age <18

• Multiple gestation

• <20 weeks gestation,
• Hemoglobin >/=11g/dL and/or hematocrit >/=33%

• Unable to read or speak English or Spanish

• Incarcerated patients